
An experimental gene therapy to boost the effectiveness of the Parkinson’s drug levodopa yielded promising results in mice, researchers report. As the loss of dopamine-releasing neurons advances in late-stage Parkinson’s, levodopa is less able to ease movement problems caused by the disease, which is a progressive disorder of the nervous system. But a Northwestern University… read on > read on >